We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

45 hedge funds and large institutions have $55.6M invested in BIND THERAPEUTICS INC in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

9% more capital invested

Capital invested by funds: $51.2M → $55.6M (+$4.36M)

7% more funds holding

Funds holding: 42 → 45 (+3)

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
10
Increased
19
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$3.55M
2
BA
BlackRock Advisors
Delaware
+$1.54M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.05M
4
RPAM
Rhenman & Partners Asset Management
Sweden
+$784K
5
Millennium Management
Millennium Management
New York
+$558K

Top Sellers

Rank Fund Capital Flow
1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$7.64M
2
EA
Emerald Advisers
Pennsylvania
-$4.93M
3
DM
Deerfield Management
New York
-$3.87M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$937K
5
RA
Royce & Associates
New York
-$830K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$24.1M +$26.4M +2,018,253 New
OM
2
Opaleye Management
Massachusetts
$5.11M +$3.55M +272,000 +175%
Franklin Resources
3
Franklin Resources
California
$4.33M +$299K +22,900 +7%
Principal Financial Group
4
Principal Financial Group
Iowa
$3.7M -$53.7K -4,115 -1%
PI
5
Putnam Investments
Massachusetts
$2.92M -$730K -55,900 -19%
BFA
6
BlackRock Fund Advisors
California
$1.82M +$150K +11,476 +8%
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.69M +$1.05M +80,383 +132%
BA
8
BlackRock Advisors
Delaware
$1.57M +$1.54M +117,605 +854%
BI
9
BVF Inc
California
$1.39M -$444K -34,000 -23%
Millennium Management
10
Millennium Management
New York
$1.38M +$558K +42,698 +59%
BIT
11
BlackRock Institutional Trust
California
$965K -$5.94K -455 -0.6%
Northern Trust
12
Northern Trust
Illinois
$810K -$95.9K -7,345 -10%
RPAM
13
Rhenman & Partners Asset Management
Sweden
$718K +$784K +60,000 New
State Street
14
State Street
Massachusetts
$591K +$192K +14,711 +42%
CS
15
Credit Suisse
Switzerland
$535K -$300K -22,986 -34%
EA
16
Emerald Advisers
Pennsylvania
$504K -$4.93M -377,629 -90%
SIM
17
SSI Investment Management
California
$394K +$122K +9,375 +40%
RJA
18
Raymond James & Associates
Florida
$392K -$8.62K -660 -2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$384K +$21K +1,605 +5%
TC
20
TFS Capital
Pennsylvania
$279K +$31.5K +2,414 +12%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$258K +$281K +21,525 New
EMFAT
22
Emerald Mutual Fund Advisers Trust
Pennsylvania
$231K -$7.64M -584,877 -97%
TCIM
23
TIAA CREF Investment Management
New York
$220K +$53.5K +4,100 +29%
BIM
24
BlackRock Investment Management
Delaware
$186K +$39K +2,983 +24%
BPC
25
Banque Pictet & Cie
Switzerland
$164K +$179K +13,740 New
1
2 3

BIND Hedge Fund Activity: Q1 2014 in Review

45 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q1 2014, worth a combined $55.6M — up 8.5% from $51.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BIND positions and 6 closed out — a net gain of 4 holders — while 19 added to existing stakes and 12 trimmed.

The largest buyer was Opaleye Management, adding an estimated $3.55M. The largest seller was Emerald Mutual Fund Advisers Trust, cutting an estimated $7.64M.

  • 45 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $55.6M of BIND THERAPEUTICS INC stock for Q1 2014, up 8.5% quarter-over-quarter.
  • 10 funds opened new BIND THERAPEUTICS INC positions in Q1 2014 and 6 closed out, a net change of +4 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q1 2014 was Opaleye Management, an estimated $3.55M added.
  • The largest BIND THERAPEUTICS INC seller in Q1 2014 was Emerald Mutual Fund Advisers Trust, an estimated $7.64M sold.

Based on aggregated 13F filings for Q1 2014.